Pharmacokinetics, metabolism and excretion of an inhibitor of inducible nitric oxide synthase, L-NIL-TA, in dog

References

• AMIN, A. R., DI CESARE, P. E., VYAS, P., ATTUR, M. G., TZENG, E., BILLIAR, T. R., STUCHIN, S. A. and ABRAMSON, S. B., 1995, The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for an inducible 'neuronal-like' nitric oxide synthase. Journal of Experimental Medicine, 182, 2097–2102.
   PubMed Web of Science ®Google Scholar
• CANNON, G. W., OPENSHAW, S. J., HIBBS, J. B., JR, HOIDAL, J. R., HUECKSTEADT, T. P. and GRIFFITHS, M. M., 1996, Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis and Rheumatism, 39, 1677–1684.
   Google Scholar
• CHARLES, I. G., PALMER, R. M., HICKERY, M. S., BAYLISS, M. T., CHUBB, A. P., HALL, V. S., Moss, D. W. and MONCADA, S., 1993, Cloning, characterization and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proceedings of the National Academy of Sciences, USA, 90, 11419–11423.
   PubMed Web of Science ®Google Scholar
• CONNOR, J. R., MANNING, P. T., SETTLE, S. L., MOORE, W. M., JEROME, G. M., WEBBER, R. K., TJOENG, F. S. and CURRIE, M. G., 1995, Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. European Journal of Pharmacology, 273, 15–24.
   PubMed Web of Science ®Google Scholar
• EVANS, C. H., STEFANOVIC-RACIC, M. and LANCASTER, J., 1995, Nitric oxide and its role in orthopaedic disease. Clinical Orthopaedics & Related Research, 312, 275–294.
   Google Scholar
• FARRELL, A. J., BLAKE, D. R., PALMER, R. M. and MONCADA, S., 1992, Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Annals of the Rheumatic Diseases, 51, 1219–1222.
   PubMed Web of Science ®Google Scholar
• HALLINAN, E. A., TSYMBALOV, S., DORN, C. R., PITZELE, B. S., HANSEN, D. W., JR, MOORE, W. M., JEROME, G. M., CONNOR, J. R., BRANSON, L. F., WIDOMSKI, D. L., ZHANG, Y., CURRIE, M. G. and MANNING, P. T., 2002, Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor. Journal of Medical Chemistry, 45, 1686–1689.
   Google Scholar
• HICKERY, M. S., PALMER, R. M. J., CHARLES, I. G., MONCADA, S. and BAYLISS, M. T., 1994, The role of nitric oxide in IL-I and TNF[alpha]-induced inhibition of proteoglycan synthesis in human articular cartilage [abstract]. Transactions of the Orthopaedic Research Society, 19, 77.
   Google Scholar
• HOBBS, A. J., HIGGS, A. and MONCADA, S., 1999, Inhibition of nitric oxide synthase as a potential therapeutic target. Annual Reviews in Pharmacology and Toxicology, 139, 191–220.
   Google Scholar
• JÄRVINEN, T. A. H., MOILANEN, T., JÁRVINEN, T. L. N. and MOILANEN, E., 1995, Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediators in Inflammation, 4, 107–111.
   Google Scholar
• MCCARTNEY-FRANCIS, N., ALLEN, J. B., MIZEL, D. E., ALBINA, J. E., XIE, Q., NATHAN, D. F. and WAHL, S. M., 1993, Suppression of arthritis by an inhibitor of nitric oxide synthase. Journal of Experimental Medicine, 178, 749–754.
   Google Scholar
• MCINNES, I. B., LEUNG, B. P., FIELD, M., WEI, X. Q., HUANG, F. P., STURROCK, R. D., KINNIMOUTH, A., WEIDNER, J., MUMFORD, R. and LIEW, F. Y., 1996, Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. Journal of Experimental Medicine, 184, 1519–1524.
   PubMed Web of Science ®Google Scholar
• MOORE, W. M., WEBBER, R. K., JEROME, G. M., TJOENG, F. S., MISKO, T. P. and CURRIE, M. G., 1994, L-N6-(1-iminoethyl) lysine: a selective inhibitor of inducible nitric oxide synthase. Journal of Medical Chemistry, 37, 3886–3888.
   PubMed Web of Science ®Google Scholar
• MURRELL, G. A. C., JANG, D. and WILLIAMS, R. J., 1995, Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochemical and Biophysical Research Communications, 206, 15–21.
   Google Scholar
• PAULSON, S. K., ZHANG, J. Y., BREAU, A. P., HRIBAR, J. D., Liu, N. W., JESSEN, S. M., LAWAL, Y. M., COGBURN, J. N., GRESK, C. J., MARKOS, C. S., MAZIASZ, T. J., SCHOENHARD, G. L. and BURTON, E. G., 2000a, Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats. Drug Metabolism and Disposition, 28, 514–521.
   PubMed Web of Science ®Google Scholar
• PAULSON, S. K., ZHANG, J. Y., JESSEN, S. M., LAWAL, Y., Liu, N. W., DUDKOWSKI, C. M., WANG, Y. F., CHANG, M., YANG, D., FINDLAY, J. W., BERGE, M. A., MARKOS, C. S., BREAU, A. P., HRIBAR, J. D. and YUAN, J., 2000b, Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey. Xenobiotica, 30, 731–744.
   PubMed Web of Science ®Google Scholar
• PELLETIER, J., JovANovic, D., FERNANDES, J. C., MANNING, P., CONNOR, J. R., CURRIE, M. G. and MARTEL-PELLETIER, J., 1999a, Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor. Osteoarthritis and Cartilage, 7, 416–418.
   Google Scholar
• PELLETIER, J. P., JovANovic, D., FERNANDES, J. C., MANNING, P., CONNOR, J. R., CURRIE, M. G., DI BATTISTA, J. A. and MARTEL-PELLETIER, J., 1998, Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis and Rheumatism, 41, 1275–1286.
   Google Scholar
• PELLETIER, J. P., LASCAU-COMAN, V., JOVANOVIC, D., FERNANDES, J. C., MANNING, P., CONNOR, J. R., CURRIE, M. G. and MARTEL-PELLETIER, J., 1999b, Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. Journal of Rheumatology, 26, 2002–2014.
   Google Scholar
• PELLETIER, J. P., MINEAU, F., RANGER, P., TARDIF, G. and MARTEL-PELLETIER, J., 1996, The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis and Cartilage, 4, 77–84.
   Google Scholar
• SAKURAI, H., KOHSAKA, H., Liu, M., HIGASHIYAMA, H., HIRATA, Y., KANNO, K., SAITO, I. and MIYASAKA, N., 1995, Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. Journal of Clinical Investigation, 96, 2357–2363.
   PubMed Web of Science ®Google Scholar
• SALERNO, L., SORRENTI, V., DI GIACOMO, C., ROMEO, G. and SIRACUSA, M. A., 2002, Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Current Pharmaceutical Design, 8, 177–200.
   PubMed Web of Science ®Google Scholar
• STEFANOVIC-RACIC, M., MEYERS, K., MESCHTER, C., COFFEY, J. W., HOFFMAN, R. A. and EVANS, C. H., 1994, N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis and Rheumatism, 37, 1062–1069.
   Google Scholar
• STEFANOVIC-RACIC, M., MEYERS, K., MESCHTER, C., COFFEY, J. W., HOFFMAN, R. A. and EVANS, C. H., 1995, Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. Journal of Rheumatology, 22, 1922–1928.
   Google Scholar
• STEFANOVIC-RACIC, M., STADLER, J. and EVANS, C. H., 1993, Nitric oxide and arthritis. Arthritis and Rheumatism, 36, 1036–1044.
   PubMed Web of Science ®Google Scholar
• TASKIRAN, D., STEFANOVIC-RACIC, M., GEORGESCU, H. I. and EVANS, CH., 1994, Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochemical and Biophysical Research Communications, 2002, 142–148.
   PubMedGoogle Scholar
• ZHANG, J. Y., WANG, Y. F., DUDKOWSKI, C., YANG, D., CHANG, M., YUAN, J., PAULSON, S. K. and BREAU, A. P., 2002, Characterization of metabolites of celecoxib in rabbits by liquid chromatography/tandem mass spectrometry. Journal of Mass Spectrometry, 35, 1259–1270.
   Google Scholar